IDE196 (LXS196), IDE196 (LXS196)
IDE196-010
Phase 3 small_molecule active
Quick answer
IDE196 (LXS196), IDE196 (LXS196) for Uveal Melanoma is a Phase 3 program (small_molecule) at IDEAYA Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IDEAYA Biosciences
- Indication
- Uveal Melanoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active